Cleared Traditional

K123765 - GUIDEZILLA GUIDE EXTENSION CATHETER

K123765 is the FDA 510(k) clearance for GUIDEZILLA GUIDE EXTENSION CATHETER by Boston Scientific. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 102-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2013
Decision
102d
Days
Class 2
Risk

K123765 is an FDA 510(k) clearance for the GUIDEZILLA GUIDE EXTENSION CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Boston Scientific (Maple Grove, US). The FDA issued a Cleared decision on March 19, 2013 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific devices

Submission Details

510(k) Number K123765 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 2012
Decision Date March 19, 2013
Days to Decision 102 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 125d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 505
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K123765.
CPS AIM UNIVERSAL SLITTABLE INNER CATHETER
K130252 · St Jude Medical · Mar 2013
CPS DIRECT UNIVERSAL SLITTABLE OUTER CATHETER
K130257 · St Jude Medical · Mar 2013
ADVANCE MICRO 14 ULTRA LOW PROFILE BALLOON DILATATION CATHETER MODEL PTA3
K122940 · Cook, Inc. · Mar 2013
SELECTRA 7F CATHETERS
K123324 · Biotronik, Inc. · Jan 2013
TRACKER-17 MICROCATHER, 150 CM LONG AND 15.0 CM FLEXIBLE DISTAL SHAFT, TRACKER-17 MICROCATHETER, 150 CM LONG AND 7.5 CM
K123452 · Stryker · Jan 2013
PENUMBRA DDC CATHETERS
K122772 · Penumbra, Inc. · Nov 2012